Effects of a one-week treatment with acid gastric inhibitors on Helicobacter pylori-infected mice

References

• Abdel-Salam OM, Czimmer J, Debreceni A, Szolcsanyi J, Mozsik G. Gastric mucosal integrity: gastric mucosal blood flow and microcirculation. An overview. J Physiol Paris 2001; 95: 105–27
   PubMed Web of Science ®Google Scholar
• Penta R, De Falco M, Iaquinto G, De Luca A. Helicobacter pylori and gastric epithelial cells: from gastritis to cancer. J Exp Clin Cancer Res 2005; 24: 337–45
   PubMedGoogle Scholar
• Moss SF, Calam J, Agarwal B, Wang S, Holt PR. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996; 38: 498–501
   PubMed Web of Science ®Google Scholar
• Mizuki I, Shimoyama T, Fukuda S, Liu Q, Nakaji S, Munakata A. Association of gastric epithelial apoptosis with the ability of Helicobacter pylori to induce a neutrophil oxidative burst. J Med Microbiol 2000; 49: 521–4
   PubMedGoogle Scholar
• Baik SC, Youn HS, Chung MH, Lee WK, Cho MJ, Ko GH, et al. Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res 1996; 56: 1279–82
   PubMed Web of Science ®Google Scholar
• Knaapen AM, Seiler F, Schilderman PA, Nehls P, Bruch J, Schins RP, et al. Neutrophils cause oxidative DNA damage in alveolar epithelial cells. Free Radic Biol Med 1999; 27: 234–40
   PubMed Web of Science ®Google Scholar
• Ulmer HJ, Beckerling A, Gatz G. Recent use of proton pump inhibitor-based triple therapies for the eradication of Helicobacter pylori: a broad data review. Helicobacter 2003; 8: 95–104
   PubMed Web of Science ®Google Scholar
• Koivisto TT, Rautelin HI, Voutilainen ME, Heikkinen MT, Koskenpato JP, Farkkila MA. First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: results of three eradication regimens. Aliment Pharmacol Ther 2005; 21: 773–82
   PubMed Web of Science ®Google Scholar
• Robinson M. Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases. Int J Clin Pract 2005; 59: 709–15
   PubMed Web of Science ®Google Scholar
• Huggins RM, Scates AC, Latour JK. Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding. Ann Pharmacother 2003; 37: 433–7
   PubMedGoogle Scholar
• Biswas K, Bandyopadhyay U, Chattopadhyay I, Varadaraj A, Ali E, Banerjee RK. A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J Biol Chem 2003; 278: 10993–11001
   PubMed Web of Science ®Google Scholar
• Natale G, Lazzeri G, Lubrano V, Colucci R, Vassalle C, Fornai M, et al. Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds. Toxicol Appl Pharmacol 2004; 195: 62–72
   PubMed Web of Science ®Google Scholar
• Kuroda M, Yoshida N, Ichikawa H, Takagi T, Okuda T, Naito Y, et al. Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis. Int J Mol Med 2006; 17: 89–93
   PubMed Web of Science ®Google Scholar
• Wandall JH. Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome B-245. Gut 1992; 33: 617–21
   PubMedGoogle Scholar
• Suzuki M, Mori M, Miura S, Suematsu M, Fukumura D, Kimura H, et al. Omeprazole attenuates oxygen-derived free radical production from human neutrophils. Free Radic Biol Med 1999; 21: 727–31
   Google Scholar
• Yoshida N, Yoshikawa T, Tanaka Y, Fujita N, Kassai K, Naito Y, et al. A new mechanism for anti-inflammatory actions of proton pump inhibitors: inhibitory effects on neutrophil-endothelial cell interactions. Aliment Pharmacol Ther 2000; 1: 74–81
   Google Scholar
• Agastya G, West BC, Callahan JM. Omeprazole inhibits phagocytosis and acidification of phagolysosomes of normal human neutrophils in vitro. Immunopharmacol Immunotoxicol 2000; 22: 357–72
   PubMed Web of Science ®Google Scholar
• Rajendra S, Mulcahy H, Patchett S, Kumar P. The effect of H2 antagonists on proliferation and apoptosis in human colorectal cancer cell lines. Dig Dis Sci 2004; 49: 1634–40
   PubMedGoogle Scholar
• Slomiany BL, Piotrowski J, Slomiany A. Endothelin-1, interleukin-4 and nitric oxide synthase modulators of gastric mucosal injury by indomethacin: effect of antiulcer agents. J Physiol Pharmacol 1999; 50: 197–210
   PubMedGoogle Scholar
• Okajima K, Harada N, Uchiba M. Ranitidine reduces ischemia/reperfusion-induced liver injury in rats by inhibiting neutrophil activation. J Pharmacol Exp Ther 2002; 301: 1157–65
   PubMedGoogle Scholar
• Mikawa K, Akamatsu H, Nishina K, Shiga M, Maekawa N, Obara H, et al. The effects of cimetidine, ranitidine, and famotidine on human neutrophil functions. Anesth Analg 1999; 89: 218–24
   PubMed Web of Science ®Google Scholar
• Shay H, Komarov AS, Fels SS, Meranze D, Gruenstein M, Siplet H. A simple method for the uniform production of gastric ulceration in rats. Gastroenterology 1945; 5: 43–61
   Web of Science ®Google Scholar
• Gamberini MT, Skorupa LA, Souccar C, Lapa AJ. Inhibition of gastric secretion by a water extract from Baccharis triptera, Mart. Mem Inst Oswaldo Cruz 1991; 86: 137–9
   PubMedGoogle Scholar
• Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78: 206–9
   PubMed Web of Science ®Google Scholar
• Pool-Zobel BL, Lotzmann N, Knoll M, Kuchenmeister F, Lambertz R, Leucht U, et al. Detection of genotoxic effects in human gastric and nasal mucosa cells isolated from biopsy samples. Environ Mol Mutagen 1994; 24: 23–45
   PubMed Web of Science ®Google Scholar
• Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, et al. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 2000; 35: 206–21
   PubMed Web of Science ®Google Scholar
• Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;184–91.
   PubMedGoogle Scholar
• Fellenius E, Berglindh T, Sachs G, Olbe L, Elander B, Sjostrand SE, et al. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H + /K + )ATPase. Nature 1981; 290: 159–61
   PubMed Web of Science ®Google Scholar
• Ozawa T, Yoshikawa N, Tomita T, Akita Y, Mitamura K. The influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with a proton pump inhibitor or an H2-receptor antagonist after bleeding from a gastric ulcer. J Gastroenterol 2003; 38: 844–8
   PubMedGoogle Scholar
• Chattopadhyay I, Nandi B, Chatterjee R, Biswas K, Bandyopadhyay U, Banerjee RK. Mechanism of antiulcer effect of Neem (Azadirachta indica) leaf extract: effect on H + –K + –ATPase, oxidative damage and apoptosis. Inflammopharmacology 2004; 12: 153–76
   PubMedGoogle Scholar
• Danon SJ, O'Rourke JL, Moss ND, Lee A. The importance of local acid production in the distribution of Helicobacter felis in the mouse stomach. Gastroenterology 1995; 108: 1386–95
   PubMed Web of Science ®Google Scholar
• Zavros Y, Rieder G, Ferguson A, Samuelson LC, Merchant JL. Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice. Gastroenterology 2002; 122: 119–33
   PubMed Web of Science ®Google Scholar
• Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997; 112: 1386–97
   PubMed Web of Science ®Google Scholar
• van Doorn NE, Namavar F, Sparrius M, Stoof J, van Rees EP, van Doorn LJ, et al. Helicobacter pylori-associated gastritis in mice is host and strain specific. Infect Immun 1999; 67: 3040–6
   PubMed Web of Science ®Google Scholar
• Elizalde JI, Mendez A, Gomez J, del Rivero M, Gironella M, Closa D, et al. Gastric mucosal blood flow changes in Helicobacter pylori infection and NSAID-induced gastric injury. Helicobacter 2003; 8: 124–31
   PubMedGoogle Scholar
• Martins de Oliveira R, Antunes E, Pedrazzoli J., Jr, Gambero A. The inhibitory effects of H + K+ATPase inhibitors on human neutrophils in vitro: Restoration by a K+ ionophore. Inflammation Res 2007. In press.
   PubMedGoogle Scholar
• Becker TL, Marostica M, Ribeiro ML, de Mendonca S, Gambero A, Pedrazzoli J, Jr. Pantoprazole treatment does not invoke anti-inflammatory properties in vivo. Int Immunopharmacol 2004; 4: 1051–7
   PubMed Web of Science ®Google Scholar
• Wadstrom T, Rydberg J, Rozalska B, Lelwala-Guruge J. Intravenous Helicobacter pylori induces low levels of TNF-alpha and IL-1 alpha in a murine model. APMIS 1994; 102: 49–52
   PubMedGoogle Scholar
• Martin DA, Elkon KB. Mechanisms of apoptosis. Rheum Dis Clin North Am 2004; 30: 441–54
   PubMedGoogle Scholar
• Nam KT, Hahm KB, Oh SY, Yeo M, Han SU, Ahn B, et al. The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model. Clin Cancer Res 2004; 10: 8105–13
   PubMedGoogle Scholar
• Hartmann A, Agurell E, Beevers C, Brendler-Schwaab S, Burlinson B, Clay P, et al. Recommendations for conducting the in vivo alkaline comet assay. Mutagenesis 2003; 18: 45–51
   PubMed Web of Science ®Google Scholar
• Brambilla G, Cavanna M, Faggin P, Maura A, Pino A, Ricci R, et al. Genotoxic effects in rodents given high oral doses of ranitidine and sodium nitrite. Carcinogenesis 1983; 4: 1281–5
   PubMedGoogle Scholar